These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22047986)

  • 1. Inhibition of translation initiation factors might be the potential therapeutic targets for HCV patients with hepatic iron overload.
    Liu Y; An D; Sun R; Jin L; Wang Q
    Med Hypotheses; 2012 Jan; 78(1):142-3. PubMed ID: 22047986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3.
    Theurl I; Zoller H; Obrist P; Datz C; Bachmann F; Elliott RM; Weiss G
    J Infect Dis; 2004 Aug; 190(4):819-25. PubMed ID: 15272411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of hepatitis C virus translation initiation by iron: role of eIF3 and La protein.
    Wang Q; Liu Y; An D; Diao H; Xu W; He X; Sun R; Wei L; Li L
    Virus Res; 2012 Aug; 167(2):302-9. PubMed ID: 22634302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
    Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
    Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
    Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
    J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
    Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus protein and iron overload induce hepatic steatosis through the unfolded protein response in mice.
    Nishina S; Korenaga M; Hidaka I; Shinozaki A; Sakai A; Gondo T; Tabuchi M; Kishi F; Hino K
    Liver Int; 2010 May; 30(5):683-92. PubMed ID: 20214734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
    Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
    J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drug targets for HIV and hepatitis C virus coinfection.
    Tedaldi EM
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S101-4. PubMed ID: 16265606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV and HGV infection, iron overload and liver disease in multitransfused patients with thalassaemia and persistently normal or abnormal transaminase levels.
    Gamberini MR; Francesconi R; Fortini M; Cavazzini L; Lari F; Scapoli C; Ballardini G; De Sanctis V; Bianchi FB
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():259-66. PubMed ID: 16462707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatitis C virus life cycle as a target for new antiviral therapies.
    Pawlotsky JM; Chevaliez S; McHutchison JG
    Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.
    Nishina S; Hino K; Korenaga M; Vecchi C; Pietrangelo A; Mizukami Y; Furutani T; Sakai A; Okuda M; Hidaka I; Okita K; Sakaida I
    Gastroenterology; 2008 Jan; 134(1):226-38. PubMed ID: 18166355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
    J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting hepatitis C virus translation: stopping HCV where it starts.
    Jubin R
    Curr Opin Investig Drugs; 2003 Feb; 4(2):162-7. PubMed ID: 12669376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload in patients with chronic viral hepatitis: how common is it?
    Riggio O; Montagnese F; Fiore P; Folino S; Giambartolomei S; Gandin C; Merli M; Quinti I; Violante N; Caroli S; Senofonte O; Capocaccia L
    Am J Gastroenterol; 1997 Aug; 92(8):1298-1301. PubMed ID: 9260793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.